Tiffany Rios

ORCID #0000-0003-1927-4362    Tiffany peq
B.S., UMET
 
Academic Program
Ph.D. Cellular and Molecular Biology

Department
Biochemistry
 
Publications
Suárez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alvarez DJ, Maldonado-Martinez G, Cubano LA, Martínez-Montemayor MM. Ganoderma lucidum combined with the EGFR tyrosine kinase inhibitor, Erlotinib synergize to reduce inflammatory breast cancer progression. J Cancer. 2016 Feb 5;7(5):200-11. PMID: 26958085 PMCID: 4780125
 
Presentations
Rios-Fuller TJ, Loperena-Alvarez Y, Lacourt-Ventura M, Lópe P, Yamamura Y, Cubano LA, Martínez-Montemayor MM.  Ganoderma lucidum extract significantly decreases stemness properties in inflammatory breast cancer cells via STAT3 regulation.  2016 ASCB Annual Meeting. San Francisco, CA (December 2016).
 
Rios-Fuller TJ, Loperena-Alvarez Y, Lacourt-Ventura M, López P, Yamamura Y, Cubano LA, Martínez-Montemayor MM. Ganoderma lucidum extract decreases stemness properties via regulation of STAT3 in IBC cells. 2016 SACNAS National Conference. Long Beach, CA. (October 2016)
 
Ríos-Fuller TJ, Loperena-Alvarez Y, Lacourt-Ventura M, López P, Yamamura Y, Cubano LA, Martínez-Montemayor MM. Ganoderma lucidum extract decreases stem cell properties via regulation of STAT3 in IBC cells. Forward Research and Innovation Summit. San Juan, PR (September 2016).
 
Rios-Fuller TJ, Loperena-Alvarez Y, Lacourt-Ventura M, Cubano LA, Martínez-Montemayor MM. GLE decreases stemness properties via STAT3 regulation in Inflammatory Breast Cancer cells. The 5th International Inflammatory Breast Cancer Conference. Boston, Massachusetts. (July 2016)
 
Rios-Fuller TJ, Suárez-Arroyo IJ, Lacourt-Ventura M, Maldonado G, Cubano L, Martínez-Montemayor MM. Ganoderma lucidum extract and Erlotinib combined decrease cell viability and tumor progression in inflammatory breast cancer. 2nd Puerto Rico Cancer Research Meeting. San Juan, PR (October 2015)
 
Rios-Fuller TJ, Suárez-Arroyo I, Lacourt-Ventura M, Cubano LA, Martínez-Montemayor MM. Combination of Erlotinib and Reishi decrease cancer cell viability and tumor progression in inflammatory breast cancer models. 2nd Puerto Rico Cell Signaling Meeting. San Juan, PR (April 2015). 
 
 
 
Awards
*Awarded 1st Place in the Poster Competition at the 2nd Puerto Rico Cancer Research Meeting in San Juan, PR, which took place in October 2015.
 
 
Travel Awards
*Oct 2015 – 2015 AACR Minority Scholar in Cancer Research Award – AACR Conference “Advances in Breast Cancer Research”
*July 2016 – 2016 SACNAS Travel Scholarship – 2016 SACNAS National Conference
*Sept 2016 – MAC Travel Award – 2016 ASCB Annual Meeting